This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...
In November, MSD made a high profile unveiling of plans for a new multi-million pound discovery centre in London – and today it has announced a heavyweight researcher to lead it. Dr Fiona ...
It licensed the compound, an anti-CD20 mAb, to London-based GlaxoSmithKline in late 2006 ... was fully developed in-house at the Boston headquarters of the Novartis Institutes of Biomedical ...
As the United Kingdom (UK) continues to attract an array of skilled and unskilled job seekers, the demand for international ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
Activist investor Elliott Investment Management has built up a sizable stake in RWE AG and is calling on the German utility’s ...
WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback